Clinical trials
Phase 2 Ovarian Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Active, not recruiting | 5 |
| Recruiting | 5 |
| Terminated | 5 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| AGO Study Group | 4 |
| North Eastern German Society of Gynaecological Oncology | 4 |
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| Hoffmann-La Roche | 2 |
| Merck Sharp & Dohme LLC | 2 |
| SOTIO a.s. | 2 |
| Translational Research in Oncology | 2 |
| AEterna Zentaris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 49 |
| Fallopian Tube Neoplasms | 13 |
| Neoplasms | 7 |
| Endometrial Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Carcinoma, Ovarian Epithelial | 5 |
| Recurrence | 5 |
| Peritoneal Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.